Purification of human basophils by density and size alone by Kepley, Christopher & NC DOCKS at The University of North Carolina at Greensboro
Purification of human basophils by density and size alone 
 
By: Christopher Kepley, Shirley Craig, Lawrence Schwartz 
 
Kepley, CL, Craig S, Schwartz L. Purification of human basophils by density and size alone. J. 
Immunol Methods 1994; 175:1-9. 
 
Made available courtesy of Elsevier: https://doi.org/10.1016/0022-1759(94)90326-3 
 
 This work is licensed under a Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License. 
 
Abstract:  
 
Basophils typically account for approximately 1% of the white cells in peripheral blood. We 
have developed a unique method for purifying basophils from whole blood of normal subjects to 
at least 95% purity. Basophils are separated from other cell types dy density-dependent 
sedimentation in Percoll and cell sorting, based solely on their size and granularity. The mean 
overall yield ranged from 5% to 28%. The procedure is typically completed within 4 h. The 
highly purified basophils obtained are functionally competent and morphologically intact. They 
release histamine in response to FceRI-mediated stimulation, express FceRI and BSP-1 ligand as 
analyzed by flow cytometry, and exhibit the known characteristic ultrastructural features of 
basophils by electron microscopy. This procedure avoids positive-selection antibodies that might 
perturb receptors on basophils or negative-selection antibodies that might activate other cell 
types, and can be used to obtain basophils for studies in vitro. 
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Article: 
 
1. Introduction 
 
 Basophils and mast cells are thought to play important roles in diseases involving IgE-
mediated, immediate-type hypersensitivity due to high affinity receptors for IgE (FceRI) on their 
cell surfaces and histamine in their secretory granules (Schwartz and Huff, 1993; Ishizaka et al. 
1972). 
 The precise involvement of the basophil in the early-phase and late-phase response to 
allergens remains poorly defined because no marker exists with adequate sensitivity and 
specificity to detect basophils in tissues or evidence for basophil activation in blood. The low 
numbers of basophils in the peripheral blood greatly limit their availability for study. Several 
procedures for the isolation of human basophils from peripheral blood have been described 
(MacGlashan, Jr. and Lichtenstein, 1980; Schroeder and Hanrahan, Jr., 1990; Bodger and 
Newton, 1987; Mulet al., 1992; Tanimoto et al., 1992; Bjerke et al., 1993). These include one-
step gradient centrifugation which usually results in purities under 50%; positive 
immunoselection with IgE and either anti-IgE antibody or antigen; and negative selection with 
antibodies that selectively recognize other cell types, such as CD2 on T lymphocytes, CD19 on B 
lymphocytes, and CD14 on monocytes. Positive selection methods for sorting basophils that bind 
to and possibly cross-link FceRI may modify the functional properties of basophils, and co-
purify unwanted B lymphocytes expressing membrane IgE or activated eosinophils and 
macrophages expressing FceRI (Gounni et al., 1994; Wang et al., 1992; Bieber et al., 1992). 
Negative selection methods, though typically performed at low temperatures to suppress signal 
transduction, may still activate other cell types if experimental conditions become permissive, for 
example, during the sorting itself. 
 Our goal was to obtain pure populations of basophils without using immunological 
reagents that are costly and might affect basophil function. To this end, a unique method was 
developed for the purification of basophils from whole blood (0.5% to 2% purity) to > 95% 
purity in less than 4 h. This method takes advantage of the unique granularity and size of the 
basophil. 
 
2. Materials and methods 
 
2.1. Materials 
 
 Percoll, CPSR-3 (controlled processed serum replacement-3), ethylenediaminetetraacetic 
acid EDTA, FITC-conjugated anti-mouse IgG and IgM, RPMI 1640, normal human AB serum, 
bovine serum albumin (BSA), non-specific mouse IgG1 (MOPC31C) and IgM (MOPC 104E), 
try-pan blue and propidium iodide (Sigma Chemical Co., St Louis, MO); Isoton II balanced 
electrolyte solution (sheath fluid) (Coulter Diagnostics, Hialeah, FL); Hanks' balanced salt 
solution (HBSS), HBSS without Ca 2+ or Mg 2+ (HBSS =) (Gibco, Grand Island, NY); CLB-
CDw49b (murine monoclonal IgG1 anti-VLA-2) (Research Diagnostics, Flanders, N J); and 
Wrights stain (Fisher Scientific, Norcross, GA) were obtained as indicated. BSP-1, an IgM 
murine monoclonal antibody recognizing a basophil surface antigen (Bodger et al., 1987), was 
provided by M.P. Bodger (Christchurch Hospital, New Zealand). The mouse monoclonal 
antibody YB5.B8 (IgG) recognizes Kit (Gadd and Ashman, 1985; Mayrhofer et al., 1987; Lerner 
et al., 1991), the cell surface receptor for the ligand termed stem cell factor (also Kit ligand, Steel 
factor or mast cell growth factor) and was provided by L.K. Ashman (University of Adelaide, 
Adelaide, Australia). The a chain of the high affinity receptor for IgE (FceRI) is recognized by 
the IgG mono-clonai antibody termed 29C6 (Riske et al., 1991), and was provided by R. 
Chizzonite (Hoffman LaRoche, Nutley, N J). 
 
2.2. Purification of human basophils 
 
 Venous blood was collected from normal volunteers who had given informed consent as 
approved by the Human Studies Committee at Virginia Commonwealth University. None were 
atopic by history. Blood specimens (50 ml) containing 0.5% to 2% basophils were 
anticoagulated with 0.01 M EDTA, diluted 1/1 with 1 × HBSS=and 12 ml layered onto 12 ml of 
45% (density 1.070 g/ml), 12 ml of 58.5% (density 1.080 g/ml), and 12 ml of 65% (density 1.09 
g/ml) Percoll, prepared essentially as described previously (Leonard et al., 1984). Densities were 
confirmed by refractometry using an American Optical refractometer (Scientific Instruments, 
Keene, NH). After centrifugation at 700 × g for 15 min at room temperature in a DPR 6000 
centrifuge (IEC, Needham Heights, MA) with a Model 269 swinging bucket rotor, basophils 
were collected predominately from the 45%/58.5% interface at purities ranging from 20% to 
45%. Percoli-enriched cells were washed three times with phosphate-buffered saline (PBS) 
containing 1% CPSR-3 and 0.01 M EDTA at 4°C, conditions designed to prevent basophil 
activation, and were then subjected to flow cytometry and cell sorting on an Epics 753 flow 
cytometer (Hialeah, FL). Sorting was performed at a flow rate of 500-1000 cells/s and a sort rate 
of 100-200 cells/s. Basophils were collected into 1.5 ml centrifuge tubes containing PBS with 
1% CPSR-3 and 0.01 M EDTA. Viability of the sorted cells was assessed by trypan blue 
exclusion. 
 
2.3. Analysis by flow cytometry 
 
 Sorted basophils were washed and resuspended in RPMI 1640 with 10% normal human 
AB serum to a concentration between 5.0 × 106 and 9.0 × l06 cells/ml at 4°C for 30 min. 
Samples were centrifuged at 400 × g for 5 rain and washed with PBS containing 1% BSA and 
0.1% sodiumazide (wash buffer). Cells were incubated with primary experimental and isotype-
matched control antibodies at concentrations indicated (see results section) for 30 min at 4°C. 
After washing three times with wash buffer, the cells were incubated with a 1/50 dilution of 
fluorescein isothiocyanate (FITC)-labeled secondary antibodies against mouse IgG and IgM 
immunoglobulins for 30 min at 4°C. Samples were washed as above. Cell pellets were 
resuspended in 200 μl of sheath fluid. Just prior to reading samples, propidium iodide (5 p.g/ml, 
final concentration) was added to each sample to detect and exclude dead cells from the analysis. 
Dead cells typically accounted for < 5% of total cells. Flow-cytometry was performed in a 
FACScan flow-cytometer (Becton and Dickinson, San Jose, CA). Cells were gated according to 
their forward and side scatter, and were analyzed for binding of primary antibodies by 
fluorescence intensity with CyCLOPS software (Cytomation, Fort Collins, CO). 
 
2.4. Histamine release 
 
 Purified basophils (50000 cells/aliquot) were washed two times with Tyrode's buffer 
containing gelatin (0.1% w/v) without calcium or magnesium (TGD =) and then resuspended in 
100 μl TGD (containing both calcium and magnesium) with 0.38 μg/ml to 3.0 μg/ml of 29C6 at 
37°C. After incubation for 30 rain the ceils were centrifuged at 900×g for 5 min at 4°C in a DPR 
6000 centrifuge. Supernatants were collected and the cell pellets were resuspended in 100 μl of 
TGD = buffer. All cell pellets were sonicated with 10 pulses (power setting #4, 50% pulse cycle, 
microtip attachment) from an Ultrasonics sonicator (model w-225, Ultrasonics, Plainview, NY) 
and centrifuged at 12000 ×g for 5 min at 4°C in a Beckman 12 microfuge (Palo Alto, CA). 
Histamine was measured by a radioimmunoassay (AMAC-Immunotech, Westbrook, ME). For 
measurement of the total histamine, 50000 unstimulated cells were lysed by sonication as above 
and centrifuged at 12000 ×g for 5 rain at 4°C to remove debris; and the supernatant was collected 
for analysis. Spontaneous histamine release was determined by incubating cells in TGD without 
stimulatory antibody. All percent release values were corrected for spontaneous release and 
calculated as: 
 
net % release 
= {(stimulated supernatant)- (spontaneous supernatant)} 
/{(stimulated pellet) + (stimulated supernatant) 
- (spontaneous supernatant)} ~ × 100 
2.5. Electron microscopy 
 
 Sorted basophils were centrifuged at 400 ×g for 5 min and the supernatant removed. 
These ceils were fixed for 90 min at 4°C in modified Karnovsky's fluid (1% glutaraldehyde, 3% 
paraformaldehyde and 4% sucrose in 0.1 M cacodylate buffer, pH 7.2). The ceils were washed 
overnight in cacodylate buffer containing 5% sucrose (three changes), postfixed in 1% osmium 
tetroxide in the same buffer with 0.5% sucrose and then dehydrated through graded ethanols 
and propylene oxide. The ceils were embedded in araldite, Fluka Durcupan ACM. Thin sections 
(60-90 nm) were cut on a Sorvall-Dupont Ultra-microtone and collected on copper grids. 
Sections were stained with uranyl acetate (Watson, 1958) and lead acetate (Reynolds, 1963) and 
examined with a JEM 1200 EX electron microscope. 
 
3. Results 
 
3.1. Basophil purification  
 
 The purity of basophils in whole blood ranged from 0.6% to 2%, and starting basophil 
numbers were estimated to range between 2 × 106 and 12 × 106 (Table 1). Basophils in whole 
blood were partially purified by density-dependent centrifugation in Percoll to purities ranging 
from 20% to 45% basophils. The estimated yield after Percoll was about 50%. Percoll-enriched 
basophils were contaminated mostly with monocytes and lymphocytes as determined by 
microscopic inspection of cytospin preparations stained with Wrights stain. 
 Basophils were further purified by cell sorting with a yield from Percoll-enriched to 
sorted basophils of 23 + 4.5% (mean + SD) (Table 1). A typical flow cytometry pattern of 
Percoll-enriched peripheral blood basophils is shown in Fig. 1. Basophils appear at a slightly 
larger size (forward scatter) and density (side scatter) than the mononuclear cells and red blood 
cells, but at a lower density than neutrophils and eosinophils (data not shown). Cells in the gated 
region labeled b in Fig. 1 were collected and found to contain 98% basophils by staining with 
Wright's stain (Fig. 2). Viability was greater than 95% in this experiment and in the other four 
purifications by trypan blue exclusion. Final concentrations were consistently >_ 95% (Table 1). 
These cells also stained with Alcian blue and exhibited metachromasia when stained with 
toluidine blue, but were not stained by alkaline phosphatase-conjugated anti-tryptase antibody 
(G3) (not shown), a selective marker for human mast cells (Irani et al., 1989). The population of 
cells just below the gate, when examined, primarily included basophils, mononuclear cells and 
erythrocytes. In Fig. 1 these cells were collected and consisted of 66% lymphocytes/monocytes, 
7% basophils, and 27% erythrocytes. 
 
3.2. Flow cytometry 
 
 The purified basophils were further examined by flow cytometry for various surface 
antigens as shown for one preparation in Fig. 3. Two separate preparations were examined, each 
giving comparable results. BSP-l-labeled basophils exhibited a multiphasic pattern, with 29% 
overlapping with the negative control (stained with irrelevant mouse IgM), the remainder (71%) 
being positive, most of these residing in a broad peak between 5 and 70 MIF. Anti-FceRIa-
labeled cells also showed a multiphasic distribution; the majority (53%) in a peak with a MIF of 
122 (99-167 MIF), another group (19%) between 39 and 97 MIF, and a third group (20%) in a 
smaller peak at a MIF between 1-38. A few ceils appeared at a MIF higher than 167. Thus, 
approximately 80% of the cells were positive for 29C6. 
 Kit, which is known to be strongly expressed on mast cells and negative or weakly 
expressed on basophils, also was examined (Fig. 4C). As anticipated, a small unimodal shift in 
the cells was observed when labeled with YB5.B8, consistent with small amounts of Kit being 
available on the surface of these cells, though only 13% of the labeled cells were outside of the 
range for the negative control. Also, one basophil preparation was negative with anti-VLA-2 
antibody, a marker for platelets, suggesting that substantial platelet contamination was unlikely. 
The pattern of surface marker expression is consistent with the purified cells being basophils. 
 
3.3. Basophil ultrastructure 
 
 Ultrastructural analysis of the sorted cells was performed by transmission electron 
microscopy. A typical cell with the characteristic features of human basophils is shown in Fig. 
4A. These include relatively short, thick extensions of the plasma membrane, and large 
cytoplasmic granules. Granules exhibit a range of patterns and electron densities with most 
exhibiting particulate material, and some also displaying myelin-like, particle-filled circles and 
homogeneous electron-dense regions (Figs. 4B,4C and 4D). These cells were morphologically 
indistinguishable from presorted basophils (not shown). Also, no evidence for platelet 
contamination was detected during this ultrastructural analysis. 
 
3.4. Basophil activation 
 
 The ability of purified basophils to release histamine was examined using an anti-FceRIa- 
chain antibody to stimulate exocytosis. The amount of histamine measured was 1.2 ± 0.11 
μg/106 basophils (mean ± SD, n = 2), which is comparable to published values (MacGlashan, Jr. 
and Lichtenstein, 1980; Schroeder and Hanrahan, Jr., 1990). Results in Fig. 5 show a dose-
dependent net% release of histamine ranging from 11% at 0.38 μg 29C6/ml to 70% at 3 μg 
29C6/ml that is FceRI-mediated. Spontaneous release was < 5% in each experiment. In another 
experiment, basophils were challenged before (28% purity) and after (98% purity) cell sorting. 
The net % release values were 54 and 57 (spontaneous release < 5%) at 2 μg 29C6/ml. Histamine 
content of basophils in this experiment was calculated as 1.1 μg/106 and 0.8 μg/106 basophils, 
respectively. The new values obtained are comparable to those in Fig. 5 and suggest that sorting 
does not select for a more activatable population of basophils. Thus, these highly purified 
preparations of Percoll-enriched and sorted basophils are functional with respect to FceRI-
mediated degranulation. 
 
4. Discussion 
 
 The method for the purification of human basophils described in the current study uses 
density-dependent sedimentation in discontinuous Percoll gradients and cell sorting by density 
and size-dependent flow cytometry. This procedure offers four advantages over others used to 
isolate basophils. First, the basophil membrane is not directly perturbed with antibody during the 
purification procedure, because no antibodies are used for positive selection. Second, negative 
selection is avoided. Activation of other cell types that might influence basophils is thus not a 
concern. Three, special immunologic reagents are not needed. Fourth, the procedure can be 
performed in about 4 h, taking basophils in 50 ml of blood from 1% to at least 95% purity with a 
total yield estimated to range from 5% to 28%. 
 Analysis of sorted cells by flow cytometry for surface markers previously shown to be 
present on human basophils further supports their identity as basophils (Fig. 3). Cells analyzed 
for FceRI showed a multiphasic distribution, suggesting variability in the amounts of this 
receptor for IgE that is available to bind anti-a-chain antibody. Basophils also were found to 
Express small amounts of surface Kit. Although an early study did not recognize this low level 
of Kit (Ashman et al., 1986), a more recent study did (Columbo et al., 1992). 
 The functionality of basophils purified in the current study was established by showing a 
dose-dependent release of histamine in response to anti-FceRIa antibody, which cross-links 
FceRI receptors. The maximal net histamine release of 70% obtained here is somewhat higher 
than values of 16-50% typically reported using anti-IgE antibodies (Ishizaka et al., 1972; 
MacGlashan, Jr. and Lichtenstein, 1980; Schroeder and Hanrahan, Jr., 1990; Mul et al., 1992; 
Riske et al., 1991; Tanimoto et al., 1992; Bjerke et al., 1993). The magnitude of degranulation 
presented here is more similar to that induced by A23187 and f-Met-Leu-Phe (Mui et al., 1992). 
Whether this apparent higher immunologic releasability is due to the milder purification 
conditions used in the current study will need further clarification. 
 Purified basophils by electron microscopy showed no evidence of damage, and no 
evidence of anaphylactic degranulation or piecemeal degranulation (Fig. 5), which are known to 
occur with basophil activation (Dvorak, 1988; Hastie, 1990; Dvorak et al., 1992). Granules 
showed varying degrees of electron density with occasional myelin-like or electron-dense figures 
over a particulate background. These granules are clearly distinguishable from the scrolls, 
gratings and lattices described for granules of mature mast cells (Craig et al., 1988; Dvorak, 
1988), and from the dense core type structures in the smaller granules of immature skin-derived 
mast cells (Craig et al., 1989). Plasma membranes exhibited relatively short, thick extensions; in 
contrast, mast ceils have more numerous extensions that are long and thin. These features of the 
purified cells described in the current study together with their nuclei with deeply divided lobes 
are consistent with these cells being mature, unstimulated human basophils. 
 
References 
 
Ashman, L.K., Gadd, S.J., Mayrhofer, G., Spargo, L.D.J. and Cole, S.R. (1986) A murine 
monoclonal antibody to an acute myeloid leukemia-associated cell surface antigen 
identifies tissue mast cells. In: A. McMichael (Ed.), Leukocyte Typing III. White Cell 
Differentiation Antigens. Oxford University Press, Oxford, p. 726. 
Bieber, T., Salle, H., Wollenberg, A., Hakimi, J., Chizzonite, R., Ring, J., Hanau, D. and Salle, 
C. (1992) Human epidermal Langerhans cells express the high affinity receptor for 
immunoglobulin E (FceRl). J. Exp. Med. 175, 1285. 
Bjerke, T., Nielsen, S., Helgestad, J., Nielsen, B.W. and Schiotz, P.O. (1993) Purification of 
human blood basophils by negative selection using immunomagnetic beads. J. Immunol. 
Methods 157, 49. 
Bodger, M.P. and Newton, L.A. (1987) The purification of human basophils: their 
immunophenotype and cytochemistry. Br. J. Hacmatol. 67, 281. 
Bodger, M.P., Mounsey, G.L., Nelson, J. and Fitzgerald, P.H. 11987) A monoclonal antibody 
reacting with human basophils. Blood 69, 1414. 
Columbo. M., Horowitz, E.M., Botana, L.M., MacGlashan, Jr., D.W., Bochner, B.S., Gillis, S., 
Zsebo, K.M., Galli, S.J. and Lichtenstein, L.M. (1992) The human recombinant c-kit 
receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and 
enhances IgE-dependent mediator release from both skin mast cells and peripheral blood 
basophils. J. lmmunol. 149, 599. 
Craig, S.S., Schechter, N.M. and Schwartz, L.B. (1988) Ultrastructural analysis of human T and 
TC mast cells identified by immunoelectron microscopy. Lab. Invest. 58, 682. 
Craig, S.S., Schechter, N.M. and Schwartz, L.B. (1989) Ultra-structural analysis of maturing 
human T and TC mast cells in situ. Lab. Invest. 61), 147. 
Dvorak, A.M. (1988) The fine structure of human basophils and mast cells. In: S.T. Holgate 
(Ed.), Mast Cells, Mediators and Disease. Kluwer Academic Publishers, London, p. 29. 
Dvorak, A.M., Warner, J.A., Morgan, E., Kissell-Rainville, S., Lichtenstein, L.M. and 
MacGlashan, Jr., D.W. (1992) An ultrastructural analysis of tumor-promoting phorbol 
diester-induced degranulation of human basophils. Am. J. Pathol. 141, 1309. 
Gadd, S.J. and Ashman, L.K. 11985) A murine monoclonal antibody specific for a cell-surface 
antigen expressed by a subgroup of human myeloid leukaemias. Leuk. Res. 9, 1329. 
Gounni, A.S., Lamkhioued, B., Ochiai, K., Tanaka, Y., Delaporte, E., Capron, A., Kinet, J.-P. 
and Capron, M. (1994) High-affinity IgE receptor on eosinophils is involved in defence 
against parasites. Nature 367, 183. 
Hastie, R. 11990) Methods in laboratory investigation: Ultra- structure of human basophil 
leukocytes studied after spray freezing and freeze-substitution. Lab. Invest. 62, 119. 
lrani, A.-M.A., Bradford, T.R., Kepley, C.L., Schechter, N.M. and Schwartz, L.B. (1989) 
Detection of MC. r and MC.rc types of human mast cells by immunohistochemistry using 
new monoclonal anti-tryptase and anti-chymase antibodies. J. Histochem. Cytochem. 37, 
1509. 
Ishizaka, T., DeBernardo, R., Tomioka, H., Lichtenstein, L.M. and lshizaka, K. 11972) The 
identification of basophil granulocytes as a site of allergic histamine release. J. Immunol. 
108, 10fl0. 
Leonard, E.J., Roberts, R.L. and Skeel, A. (1984) Purification of human blood basophils by 
single step isopycnic banding on Percoll. J. Leuk. Biol. 35, 169. 
Lerner, N.B.. Nocka. K.H., Cole. S.R., Qiu, F.H., Strife, A., Ashman, L.K. and Besmer, P. 
(1991) Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 
77, 1876. 
MacGlashan, Jr., D.W. and Lichtenstein, L.M. (1980) The purification of human basophils. J. 
Immunol. 124, 2519. 
Mayrhofer. G., Gadd. S.J., Spargo, L.D. and Ashman. L.K. 11987) Specificity of a mouse 
monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in 
human mucosal and connective tissues. Immunol. Cell Biol. 65, 241. 
Mul, F.P.J., Knol, E.F. and Roos, D. (1992) An improved method for the purification of 
basophilic granulocytes from human blood. J. Immunol. Methods 149, 207.  
Reynolds, E. 11963) The use of lead citrate as an electronopaque stain in electron microscopy. J. 
Cell Biol. 17, 208. 
Riske, F., Hakim, J., Mallamaci, M., Griffin, M., Pilson, B., Tobkes, N., Lin, P., Danho, W., 
Kochan, J. and Chizzonite, R. (1991) tligh affinity human IgE receptor (FceRI). Analysis 
of functional domains of the a-subunit with monoclonal antibodies. J. Biol. Chem. 266, 
11245. 
Schroeder, J.T. and Hanrahan, L.R., Jr. (1990) Purification of human basophils using mouse 
monoclonal IgE.J. Immunol. Methods 133, 269. 
Schwartz. L.B. and Huff, T.F. (1993) Biology of mast cells and basophils. In: E. Middleton, Jr., 
C.E. Reed, E.F. Ellis, N.F. Adkinson, Jr., J.W. Yunginger and W.W. Busse (Eds.), 
Allergy: Principals and Practice, Vol.4. Mosby-Year Book, St. Louis, MO, p. 135. 
Tanimoto, Y., Takahashi, K., Takata, M., Kawata, N. and Kimura, I. 11992) Purification of 
human blood basophils using negative selection by flow cytometry. Clin. Exp. Allergy 
22, 1015. 
Wang, B., Rieger. A.. Kilgus, O., Ochiai, K., Maurer, D., Fodinger, D., Kinet, J.-P. and Sting, G. 
(1992) Epidermal Langerhans cells from normal human skin bind monomeric IgE via 
FceRI.J. Exp. Med. 175, 1353. 
Watson, M.L. (1958) Staining of tissue sections for electron microscopy with heavy metals. J. 
Biophys. Biochem. Cytol. 4, 475. 
